Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial-Reference-Cited by-同舟云学术

Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial

Published:2018-05 Issue:2 Volume:127 Page:206-212
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Quon Harvey C.,Ong Aldrich,Cheung Patrick,Chu William,Chung Hans T.,Vesprini Danny,Chowdhury Amit,Panjwani Dilip,Pang Geordi,Korol Renee,Davidson Melanie,Ravi Ananth,McCurdy Boyd,Zhang Liying,Mamedov Alexandre,Deabreu Andrea,Loblaw Andrew

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference28 articles.

1. Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy;Miralbell;Int J Radiat Oncol Biol Phys,2012

2. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial;Dearnaley;Lancet Oncol,2016

3. Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer;Lee;J Clin Oncol,2016

4. A randomized trial of a shorter radiation fractionation schedule for the treatment of localized prostate cancer;Catton;J Clin Oncol,2016

5. Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: Toxicity, biochemical, and pathological outcomes;Loblaw;Radiother Oncol,2013

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT-Guided Online Adaptive Radiotherapy Delivered via Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) for a Bulky Thoracic and Abdominal Mass in Oligometastatic Renal Cell Carcinoma;Cureus;2024-08-22

2. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

3. An AI-based approach for modeling the synergy between radiotherapy and immunotherapy;Scientific Reports;2024-04-08

4. Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).;Strahlentherapie und Onkologie;2024-01-05

5. Late Toxicity of Prostate Ultrahypofractionated Radiation Therapy Compared With Moderate Hypofractionation in a Randomized Trial;International Journal of Radiation Oncology*Biology*Physics;2023-11